The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK.
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Wilmslow Road, Manchester, M20 4BX, UK.
BMC Womens Health. 2023 Jan 13;23(1):17. doi: 10.1186/s12905-023-02162-0.
Obesity in early adulthood is associated with lower breast cancer rates in later life. This could be interpreted as a positive reinforcement of excess weight amongst younger women however, the wider implications of higher weights are less well known. This study examined the association between both obesity in early adulthood and body mass index (BMI) change through adulthood, and all-cause mortality.
The Predicting Risk of Cancer At Screening (PROCAS) study recruited 57,902 women aged 46-73 years (median age 57.2, IQR 51.8-63.7 years) from the Greater Manchester National Health Service breast screening programme in North West England between 2009 and 2015. It was used to assess associations between BMI at 20 years and cohort entry with all-cause mortality ascertained via deaths recorded on the National Breast Screening System to June 2020. Hazard ratios were estimated using proportional hazards (Cox) regression adjusted for factors at entry to the cohort: age, deprivation, bilateral oophorectomy, hormone-replacement therapy, menopausal status, ethnicity, alcohol intake, physical activity, and BMI.
The prevalence of overweight (25-30 kg/m) and obesity (> 30 kg/m) were 10.4% and 2.5% respectively at 20 years, increasing to 35.2% and 25.9% respectively at cohort entry. After a mean 8.7 years follow-up we observed that overweight (HR = 1.27, 95%CI = 1.10-1.47) and obesity (HR = 2.11, 95%CI = 1.67-2.66) at 20 years had a higher mortality rate compared with healthy weight. Women who were underweight/healthy weight at 20 years and gained weight to obesity at entry had a slightly increased mortality rate compared with women who were underweight/healthy weight at both time points (HR 1.16, 95%CI = 1.02-1.32). Women with overweight (HR = 1.36, 95%CI = 1.06-1.75) or obesity (HR = 1.90, 95%CI = 1.45-2.48) at both 20 years and entry had a higher mortality rate than women who were underweight/healthy weight at both points.
Women who self-reported overweight and obesity at 20 years had a shorter life expectancy in this cohort of women attending breast cancer screening. Weight gain from 20 years was common in this group. Girls and women should be supported to maintain a healthy weight throughout the lifespan to help increase life expectancy. Trial registration number NCT04359420, retrospectively registered 24/04/2020.
成年早期肥胖与晚年较低的乳腺癌发病率有关。这可能被解释为对年轻女性超重的积极强化,但体重增加的更广泛影响却鲜为人知。本研究通过成年期的早期成年肥胖和体重指数(BMI)变化来检查与全因死亡率之间的关系。
预测癌症筛查风险(PROCAS)研究招募了 57902 名年龄在 46-73 岁之间的女性(中位年龄 57.2 岁,IQR 51.8-63.7 岁),来自英格兰西北部大曼彻斯特国民保健服务乳腺癌筛查计划,时间为 2009 年至 2015 年。它用于评估 20 岁时 BMI 与全因死亡率之间的关联,全因死亡率通过截至 2020 年 6 月在国家乳房筛查系统中记录的死亡情况来确定。使用比例风险(Cox)回归来估计风险比,该回归根据队列进入时的因素进行了调整:年龄、贫困、双侧卵巢切除术、激素替代疗法、绝经状态、种族、酒精摄入量、身体活动和 BMI。
20 岁时超重(25-30kg/m)和肥胖(>30kg/m)的患病率分别为 10.4%和 2.5%,在队列进入时分别增加到 35.2%和 25.9%。在平均 8.7 年的随访后,我们发现 20 岁时超重(HR=1.27,95%CI=1.10-1.47)和肥胖(HR=2.11,95%CI=1.67-2.66)的死亡率较高。与两个时间点都处于体重不足/健康体重的女性相比,20 岁时体重不足/健康体重且体重增加到肥胖的女性死亡率略有增加(HR 1.16,95%CI=1.02-1.32)。20 岁时超重(HR=1.36,95%CI=1.06-1.75)或肥胖(HR=1.90,95%CI=1.45-2.48)且进入时超重或肥胖的女性死亡率高于两个时间点均体重不足/健康体重的女性。
在参加乳腺癌筛查的这群女性中,自我报告 20 岁时超重和肥胖的女性预期寿命较短。该组人群体重增加较为普遍。女孩和妇女应得到支持,以帮助增加预期寿命,使其在整个生命周期中保持健康的体重。试验注册号 NCT04359420,2020 年 4 月 24 日回顾性注册。